Medartis (MDRSF) Stock Price, News & Analysis

Company Overview

Medartis AG is a Swiss medical technology company specializing in the design, development and marketing of osteosynthesis solutions for small bone fixation. Headquartered in Basel, the company focuses on implants and instruments for hand, wrist, elbow, foot and ankle surgeries, addressing both trauma and reconstructive indications.

The company’s product portfolio includes anatomically pre-contoured plating systems, locking screws, intramedullary nails and guided instrumentation. Medartis emphasizes modularity and precision in its offerings, combining titanium and stainless-steel implants with advanced surgical toolsets. Its solutions are used by orthopedic and trauma surgeons to support fracture healing and restore function in complex small-bone anatomies.

Founded in 1997 as a spin-off from Swiss academic research, Medartis has expanded its presence through subsidiaries and distribution partnerships across Europe, North America, Asia and Latin America. Over the years, the company has grown to employ several hundred professionals in research, manufacturing and global sales, underpinned by quality-focused manufacturing processes in Switzerland.

In August 2022, Medartis agreed to be acquired by Stryker Corporation, a leading global medical technologies firm, in a move designed to broaden Stryker’s small-bone fixation capabilities. The acquisition underscores the strategic value of Medartis’s specialized portfolio and its commitment to innovation in orthopedic trauma care.

Key Stats

• Today's Range: C$102.01 to C$102.01
• 50-Day Range: C$51.70 to C$102.01
• 52-Week Range: C$51.50 to C$102.01
• Volume: N/A
• Average Volume: 300 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

MDRSF Stock Analysis - Frequently Asked Questions

How have MDRSF shares performed this year?

Medartis' stock was trading at C$51.70 at the start of the year. Since then, MDRSF stock has increased by 97.3% and is now trading at C$102.01.

How do I buy shares of Medartis?

Shares of MDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MDRSF
• CIK: N/A
• Web: www.medartis.com
• Phone: 41 61 633 34 34
• Fax: N/A
• Employees: 860
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A